Michael Dell (Richard Drew/AP Images)
$200M SPAC funded by billionaire Michael Dell will unwind after failing to find a partner
The biopharma industry may be doing deals again, but SPACs are being left out of the recent wave.
Orion Biotech Opportunities Corp., a blank …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
